Executive Summary
On the day the U.S. lost its measles-elimination status, BMS CEO Chris Boerner warned against “policies that don’t” protect the drug ecosystem.
Business Context
‘It’s not a birthright’: Bristol Myers Squibb CEO warns America about vaccines and losing its measles elimination is relevant for readers tracking markets, technology, wealth creation, and global business strategy.
Investor Takeaway
The key signal is whether this development changes demand, margins, capital allocation, competitive advantage, or risk expectations.
Credit:
This article is based on publicly available source data and editorial synthesis.
Source: Open original source
Source: Open original source